20-176 - Traditional Versus Early Aggressive Therapy for Multiple Sclerosis TrialStatus: open
A Pragmatic Trial to Evaluate the Intermediate-term Effects of Early, Aggressive Versus Escalation Therapy in People With Multiple Sclerosis
If you have questions about this trial or are interested in participating, please contact this Clinical Trial’s Coordinator by email at email@example.com.
This is a randomized trial for multiple sclerosis. The purpose is to evaluate disability risk between early aggressive therapy and traditional first-line therapy. Subject will be randomized to receive one of the two treatment types and will be evaluated over a 4 year period.
SponsorsThis trial is sponsored by Patient-Centered Outcomes Research Institute (PCORI).
Providers Associated With This Trial
- William Kilgo, M.D.NeurologistDirector of the Neurology Residency Program; Assistant Professor of Neurology